Wespac Advisors, LLC Zoetis Inc. Transaction History

Wespac Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$111.92 - $142.53 $482,599 - $614,589	-4,312 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$92.66 - $144.94 $67,456 - $105,516	-728 Reduced 14.44%	4,312 $507,000
Q4 2019 Feb 07, 2020	SELL	$116.25 - $133.25 $28,713 - $32,912	-247 Reduced 4.67%	5,040 $667,000
Q3 2019 Oct 29, 2019	BUY	$112.57 - $128.43 $595,157 - $679,009	5,287 New	5,287 $659,000
Q4 2018 Jan 31, 2019	SELL	$79.28 - $95.27 $582,311 - $699,758	-7,345 Closed	0 $0

Q3 2018 Nov 02, 2018	BUY	$83.5 - $93.23 $613,307 - $684,774	7,345 New	7,345 $673,000

1,862

416M

1.13M

1.81M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.